City
New York
1,754 announced deals involving New York, most recent first, with the firms that advised on each.
Most recent
SEARCH ALL 1,754 DLA Piper advises IMVIONIX on US and Canadian commercial rights for retinal therapy 11 Nov 2026
Clifford Chance advises on MIGA-backed financing for Bogotá’s first metro line 11 Nov 2026
Latham & Watkins Advises Codexis on US$60 Million Term Loan Facility 11 Nov 2026
Latham & Watkins Advises Diamondback Energy on Acquisition of Deep Blue Midland Basin 11 Nov 2026
Latham & Watkins Advises on Orchestra BioMed’s US$75 Million Public Offering 9 Nov 2026
Latham & Watkins Advises Bowman Consulting Group in Completed US$1 Billion Take-Private Acquisition by Bernhard Capital Partners 9 Nov 2026
Latham & Watkins Advises on ZF’s US$800 Million Notes Offering and Tender Offers 6 Nov 2026
Latham Advises ECP on Acquisition of 892 MW Natural Gas-Fired Cogeneration Portfolio 5 Nov 2026
Latham & Watkins Advises AbbVie on Global License Agreement With Nxera Pharma 5 Nov 2026
Latham & Watkins Advises Viper Energy on McElroy Ranch and Buckhorn Minerals Acquisitions 5 Nov 2026
Latham & Watkins Advises Penguin Solutions in Sale of Cree LED to Transom Capital Group 5 Nov 2026
Latham & Watkins Represents I Squared Capital in Close of Infrastructure Credit Strategy With US$3 Billion of Commitments 5 Nov 2026
Hogan Lovells Cadwalader advises Civitas Capital Group in providing construction loan for InterContinental Orlando 3 Nov 2026
Latham & Watkins Advises Vistra on Completed Acquisition of Cogentrix Natural Gas Portfolio 3 Nov 2026
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Latham & Watkins Advises on Bambusa Therapeutics’ Upsized US$168.9 Million IPO 3 Nov 2026
Latham & Watkins Advises DoorDash on US$17 Billion Acquisition of Instacart 3 Nov 2026
Latham Advises A. O. Smith on Definitive Agreement With CPE 3 Nov 2026
Latham & Watkins Advises Platinum Equity in Acquisition of Energy Distribution Partners 29 Oct 2026
Latham & Watkins Advises Triton on Sale of Trench to GE Vernova 29 Oct 2026
Latham Advises Jio Platforms on INR 301,876 Million (US$3.2 Billion) IPO 29 Oct 2026
Linklaters advises thyssenkrupp on the spin-off and listing of tk accelis 29 Oct 2026
DLA Piper advises underwriters in Strive’s US$630 million preferred stock initial public offering 28 Oct 2026
Clifford Chance advises CAF on A/B Loan to Pan American Energy, S.L., Sucursal Argentina 28 Oct 2026
Latham Advises CoStar Group in US$730 Million Acquisition of Vexcel 28 Oct 2026
Latham Advises Guidewire on Acquisition of hyperexponential 28 Oct 2026
Clifford Chance advises the underwriters on CAF’s US$2 billion notes offering 27 Oct 2026
Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 27 Oct 2026
Latham Advises on Corxel Pharmaceuticals and Amanat Acquisition Corp.’s Business Combination Agreement to Create a Publicly Listed Obesity-Focused Biopharmaceutical Company 27 Oct 2026
Latham & Watkins Advises LSEG on US$3.535 Billion Acquisition of Octus 27 Oct 2026
Linklaters advises RENK on sale of Slide Bearings to Miba 27 Oct 2026
Linklaters advises QIAGEN on recommended voluntary all-cash public takeover offer by EQT 27 Oct 2026
Clifford Chance advises Luxinva on the voluntary public takeover offer of QIAGEN NV 22 Oct 2026
News Clifford Chance advises on MUFG’s inaugural Australian dollar AT1 issuance 22 Oct 2026
Latham Advises on Smith & Wesson’s Acquisition of Savage Arms 22 Oct 2026
Latham Advises HPS on Investment in SBTH Asia Holdings Pte. Ltd. 22 Oct 2026
Clifford Chance advises Aligned Climate Capital on ~US$387 million financing for 126 MW solar portfolio 21 Oct 2026
Latham & Watkins Advises Melange Capital Partners as Lead Investor in EnCap’s US$3.5 Billion Minerals Continuation Vehicle 21 Oct 2026
Latham & Watkins Advises Morgan Stanley Capital Partners on Acquisition of The Rapid Group 21 Oct 2026
Latham & Watkins Advises Trumid in US$1.97 Billion Acquisition by Tradeweb 21 Oct 2026
TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (Nasdaq: TCGX), a special purpose acquisition company (SPAC) sponsored by TCGX, have announced the execution of a definitive business combination agreement that will result in TriGemX Bio becoming a publicly traded company. The combined company will be named TriGemX Bio, Inc. and is expected to trade on Nasdaq under the new ticker symbol TGEM. Latham & Watkins LLP represents TCGX in the transaction with a corporate team led by Houston partners Ryan Maierson and Ryan Lynch, with associates Taylor Allison, Cooper Shear, and Luisa Gomez Yokubaitis, with assistance from Zachary Mouton. Advice was also provided on tax matters by Houston partner Jared Grimley, with associates Dominick Constantino and Graham Core; on benefits matters by Los Angeles partner Michelle Carpenter, with associate Jordan Barnes; on healthcare regulatory matters by Washington, D.C. partner Nathan Beaton and counsel Nicole Liffrig Molife and Chad Jennings, with associate Margaret Rote; on funds matters by Chicago partner David Moore and New York partner Jennifer Tian;* on data cybersecurity matters by New York partner Jessica Cohen, with associates Laura Geraci and Nat Lewis; on data privacy and cybersecurity matters by Bay Area partner Heather Deixler, with associate Ryleigh Chen; on environmental matters by Los Angeles/Houston partner Joshua Marnitz, with associate Brandon Kerns; on anti-bribery and anti-money laundering matters by Washington, D.C. partner Daniel Dominguez, with associates Patricia Amselem Bensadon and Ai Ni Lim; on antitrust matters by Washington, D.C. partner Jason Cruise and Washington, D.C. counsel Ngoc Hulbig; and on economic sanctions and export controls matters by Washington, D.C. partner Eric Volkman, with associate Amulya Vadapalli. *Admitted to practice in Illinois only. 21 Oct 2026
Latham Advises The Sterling Group on Partnership With United Window & Door Manufacturing 21 Oct 2026
Mayer Brown advises BNR Power Investments B.V. on $430 million sale of interest in YPF Luz to YPF S.A. 19 Oct 2026
DLA Piper advises Hyundai Transys Georgia Powertrain on US$560 million expansion 19 Oct 2026
DLA Piper advises POSCO International on US$550 million agreement to acquire Chord’s Marcellus gas assets 19 Oct 2026
DLA Piper guides First Digital through De-SPAC business combination with KOYN 19 Oct 2026
DLA Piper guides on the acquisition of Wesbell Communications Holding Inc. 19 Oct 2026
Latham & Watkins Advises Zocdoc on Acquisition of Sohar Health 19 Oct 2026
Latham Advises on Select Water Solutions’ Upsized US$900 Million Senior Notes OfferingLatham Advises on Select Water Solutions’ Upsized US$900 Million Senior Notes Offering 19 Oct 2026
Latham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLsLatham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLs 19 Oct 2026
Latham & Watkins Advises The Knot Worldwide in Agreement Adding Zola to Global Brand Portfolio 19 Oct 2026
Linklaters Advises Qatar Investment Authority on American Express Global Business Travel’s $6.3bn Acquisition by Long Lake Management 19 Oct 2026
Latham & Watkins Advises Partners Group on Investment in Scanntech 14 Oct 2026
Latham & Watkins Advises Magnite on Successful Completion of Term Loan and Revolving Credit Facility Repricing 14 Oct 2026
Latham & Watkins Advises Ares Management Corporation on €1 Billion Capital Contribution to Plenitude 14 Oct 2026
Latham & Watkins Advises Initial Purchasers on €1 Billion High-Yield Bond Issuance by Guala Closures 14 Oct 2026
Hogan Lovells Cadwalader advises the Central America Bottling Corporation in a benchmark US$875 million notes offering and related cash tender offer 9 Oct 2026
Latham & Watkins Advises Stuut on US$52.5 Million Series B Financing 9 Oct 2026
Linklaters Advises Itaú on US$300 Million Financing for Fértil Pampa S.A.U. 9 Oct 2026